| VITAL: Paricalcitol reduced renal, CV risks in patients with diabetic nephropathy - Endocrine Today |
|
|
Endocrine TodayAdding 2 mcg per day of paricalcitol to renin-angiotension-aldosterone system inhibition appears to be a novel approach to lower residual renal risk for ... read more |